Skip to main content

Table 4 Comparison between cases with and without CTRCD regarding ECHO parameters after 3 months

From: Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer

After 3 months

Without CTRCD

With CTRCD

Test value

P-value

Sig

No. = 70

No. = 24

LVEDD

Mean ± SD

47.84 ± 3.87

50.88 ± 4.50

-3.173b

0.002

HS

Range

40 – 56

43 – 58

LVESD

Mean ± SD

31.79 ± 3.43

37.42 ± 4.36

-6.464b

0.000

HS

Range

25 – 39

29 – 46

LA

Mean ± SD

36.53 ± 3.45

37.83 ± 2.87

-1.664b

0.099

NS

Range

28 – 45

32 – 45

Diastolic degree

Normal

11 (15.7%)

1 (4.2%)

2.140a

0.143

NS

Grade I

59 (84.3%)

23 (95.8%)

Grade II

0 (0.0%)

0 (0.0%)

Grade III

0 (0.0%)

0 (0.0%)

EF M mode

Mean ± SD

62.07 ± 4.06

52.50 ± 5.65

8.974b

0.000

HS

Range

55 – 74

35 – 60

EF Simpson’s method

Mean ± SD

59.13 ± 2.53

49.54 ± 5.63

11.356b

0.000

HS

Range

54 – 65

35 – 59

RV S’

Mean ± SD

12.74 ± 1.29

9.42 ± 0.97

11.515b

0.000

HS

Range

9 – 15

8 – 11

GLS %

Mean ± SD

-17.80 ± 1.88

-13.54 ± 1.91

-9.539b

0.000

HS

Range

-22 – -13

-19 – -9

GCS %

Mean ± SD

-24.37 ± 1.73

-21.83 ± 2.51

-5.488b

0.000

HS

Range

-28 – -21

-26 – -15

GRS %

Mean ± SD

45.00 ± 6.28

42.08 ± 8.03

1.825b

0.071

NS

Range

32 – 58

26 – 57

RV GLS%

Mean ± SD

-22.14 ± 2.92

-15.38 ± 2.57

-10.101b

0.000

HS

Range

-26 – -13

-24 – -12

RV FWLS %

Mean ± SD

-24.36 ± 3.18

-17.13 ± 2.42

-10.163b

0.000

HS

Range

-28 – -15

-26 – -14

  1. aChi-square test
  2. bIndependent t-test